CD69 and neoplasm: Consistent with a requirement for T-cell responses in the observed tumor suppressive effects by anti-PD-L1 blockade, both activated CD69+/CD8+ and IFNγ+/CD8+ T cells correlated with changes in survival in the different treatment groups (Fig. 5f, g; Supplementary Fig. 8c).